HOUSE 5429118th CongressReferred to the Subcommittee on Health.

Medication Affordability and Patent Integrity Act

Last Action: 9/15/2023

Actions

2023-09-15Referred to the Subcommittee on Health.
2023-09-13Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-09-13Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-09-13Introduced in House
2023-09-13Introduced in House

Cosponsors (1)

Diana Harshbarger (R-TN)

Subjects

Drug safety, medical device, and laboratory regulation
Inflation and prices
Intellectual property
Manufacturing
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.